跳至主要内容
临床试验/IRCT20210702051763N1
IRCT20210702051763N1招募中3 期

The effect of vitamin D and magnesium supplementation on clinical symptoms, inflammatory markers and oxidative stress in patients with COVID-19: double-blind randomized control clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • People aged 18-65
  • confirmation of Covid-19 infection by RT-PCR test
  • completing informed consent
  • less than 48 hours have passed since the patient was hospitalized
  • no skin or gastrointestinal allergies due to taking multivitamin supplements, vitamin D, and magnesium
  • people with more than 30 breaths per minute and less than 93% oxygen saturation in room air and sea level.

排除标准

  • Pregnancy or lactation
  • take a daily multivitamin or take a vitamin D or magnesium supplement in the last month
  • participating in other clinical studies
  • renal failure or dialysis, severe liver disease or cirrhosis
  • known diagnosis of hypercalcemia
  • patients who discharged from the hospital less than 24 hours after the start of the intervention
  • history of kidney stones in the last year
  • transfer the patient to the ICU
  • baseline vitamin D levels above 80 ng/ml
  • baseline magnesium levels above 2.6 mg/dl.

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验